General Proximity
General Proximity is a biotechnology company pioneering next-generation "proximity medicines" that control biological processes by inducing proximity between molecular targets. Its multi-target OMNITAC platform is used to discover and advance novel therapeutics, including an oncology collaboration with Daiichi Sankyo. The company is backed by investors including Felicis and Y Combinator, and has drawn investment from Freemind and Daewoong Pharmaceutical. This is a company profile in the API Evangelist network; General Proximity is a drug-discovery company and does not publish a public API, developer portal, or machine-readable API artifacts at this time.
General Proximity is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Drug Discovery, and Proximity Medicines.
General Proximity’s developer surface includes engineering blog, product news, and 5 more developer resources.
Kin Score
Resources
Company 6
The organization behind the API
Other 1
Properties that don't map to a standard resource type